Journal of Gastroenterology Research

Dr. Sarwar Hashmi is working as Head for Developmental biology Lab, New Jersey. Dr. Hashmi completed his Ph. D from University Maryland, College Park, 1994. His major achievements include patents pending on development of recombinant insecticidal nematode, development of a gene transfer method and he also received Recipient National award Food and Agriculture Organization, Italy and Pakistan, 1992, USDA-NRI competitive grantee Rutgers University, since 1996.

Dr. Suresh K. Balani is working as Director in Drug Metabolism and Pharmacokinetics Department at Takeda Pharmaceuticals International Co. in Cambridge, MA, directing preclinical drug development in Gastro-Intestinal and Central Nervous System diseases. Dr. Balani received his Ph.D. from Queen's University of Belfast, Northern Ireland, U.K., and subsequently Dr. Balani worked at National Institutes of Diabetes, Digestive and Kidney Diseases, NIH in Bethesda, MD; Merck Research Labs at West Point, PA; and DuPont Pharmaceuticals at Wilmington, Delaware. In the past he has worked in the Oncology, Metabolic Diseases and Cardiovascular areas and contributed to R&D of drugs Indinavir, Sustiva, Singulair, Tirofiban, Caspofugin, Adcetris, and Ixazomib. Recently, he contributed to Entyvio for CD and UC in the US. His main interests include preclinical development of GI and CNS drugs by targeting different enzymes or proteins, with emphasis on innovative science. In the GI area, IBD and Gastroparesis have been the recent focus, investigating both small molecules and protein therapeutics for the development.

Dr. Claudio Tiribelli is working as Professor from Department of Gastroenterology at University of Trieste. Dr. Tiribelli is also working as Head of the Medical Department, Teaching Hospital, Trieste and Dr. Tiribelli is Director for Liver Research Center, Trieste. Dr. Tiribelli received Laurea Honoris Causa from Universidad Nacional de Rosario; Laurea Honoris Causa from Universidad Favaloro, Argentina.

Dr. John K Triantafillidis, Head to Inflammatory Bowel Disease Unit, 'IASO General Hospital', Athens, Greece (2013) and also Visiting professor, Department of Gastroenterology, University of Washington, Seattle, U.S.A. (1995). He is Associate Professor, Medical University of IASI, Romania (since 2007). Dr. Triantafillidis started his career as a research Fellow Gastroenterology Unit, University of Oxford, UK (1981-1982), then as the Head of Department of Gastroenterology 'METAXAS' Cancer Hospital, Piraeus, Greece (1988-1991) and as Head of Department of Gastroenterology 'Saint Panteleimon' General State Hospital, Greece during 1991-2013. His research interests include: Inflammatory Bowel Disease; Digestive Oncology.

Dr. Domenico Rubello obtained his post-graduate academic degree in Endocrinology and Nuclear Medicine from Padova University, Italy. Dr. Rubello is Head of the Nuclear Medicine Service & PET/CT Centre at Rovigo General Hospital in Veneto ( Italy) from 2004; He is Director of the Department of Imaging (Nuclear Medicine & PET/CT Centre, Radiology, NeuroRadiology, Medical Physics) at Rovigo General Hospital in Veneto (Italy) from 2008; Dr. Rubello has been Professor of Radiation Oncology at the Post-graduate Radiotherapy and Oncology Medical School of Padova University; Dr. Rubello is Professor of Radioguided Surgery at the Postgraduate Surgery Medical School of Padova University; He is Professor of Nuclear Medicine at the Postgraduate Surgery Medical School of Pisa University; Dr. Rubello has been Professor of Chemistry and Radiochemistry at Padova University, Italy. He has been Professor of Nuclear Medicine and Radiotherapy at Medical School of Technicians in Radiology, Nuclear Medicine and Radiotherapy at Padova, Asolo and Rovigo Hospitals; He is Professor of Nuclear Medicine at Medical School of Technicians in Radiology, Nuclear Medicine and Radiotherapy at Padova University.

Dr. Daolin Tang is currently working as an Associate Professor in Department of Surgery at University of Pittsburgh. Dr. Tang received his medical degree from Norman Bethune University of Medical Sciences in 2000 and his PhD degree from Central South University in 2007. Dr. Tang received several awards like Pancreatic Cancer Action Network-AACR Career Development Award, NanoString Technologies Award, The Thousand Talents Program for Distinguished Young Scholars (China), etc. His research interests include Regulation and function of Damage-Associated Molecular Pattern Molecules (DAMPs), e.g., high mobility group box 1 (HMGB1) and histone, in cell injury, cell death (e.g., apoptosis, necrosis, necroptosis, proptosis and ferroptosis), adaptation (e.g., autophagy), and their pathophysiological role in cancer (e.g., pancreatic cancer and leukemia) and inflammatory disease (e.g., pancreatitis and sepsis).

Dr. Jagdish Khubchandani is an Associate Professor of Community Health and has been a member of Ball State University since 2010. He has doctoral degrees in Clinical Medicine and Health Education. He has served as a faculty fellow for the BSU Global Health Institute and Center for International Development. His research interests are in the field of Clinical and Social Epidemiology, Community and Global Health. His research has been highlighted by popular media outlets like Fox News, US News and World Report, CNBC, Yahoo News, Huffington Post, and the Chicago Tribune. He received several Awards: Governor's Award for Service Learning from Government of Indiana, Diversity Associate Scholar and Outstanding Junior Faculty from Ball State University, Harold G Wolff Lecture Award from American Headache Society, etc.

Dr. Charmaine A Stewart is currently working as an Associate Professor in Department of Gastroenterology and Hepatology at University of Wisconsin School of Medicine and Public Health, Wisconsin. Dr. Stewart is also working as Staff Physician at William S. Middleton Veterans Administration Hospital in Madison. She received her medical degree from Tufts University School of Medicine and has been in practice for more than 20 years. Dr. Stewart received several Awards: Travel Award - American Society of Clinical Investigation, National Research Service Award - National Institutes of Health, etc. Her research interest include General Gastroenterology, Hepatology & Liver Transplantation.

Dr. Udai P Singh is working as an Associate Professor in Department of Pathology, Microbiology and Immunology at South Carolina University, Columbia. Dr. Singh is internationally recognized mucosal immunologist working in the area of inflammation since last 16 years. Dr. Singh research contributions span multiple disciplines including cellular and mucosal immunology of autoimmune diseases, alternative medicine as therapeutics for inflammatory bowel disease (IBD), interstitial cystitis and aging. Dr. Singh obtained his Ph.D. degree from Banaras Hindu University. At present Dr. Singh focusing on how a plant derived compound and/or dietary supplement mediate inflammation and related aging. Dr. Singh long time career goal is to understand how alternative medicine remedies mediate IBD and inflammation in general that leads to prevents aging. Dr. Singh primary research interest includes in the area of cellular and mucosal immunology, chemokines, immunotherapy and complimentary and alternative medicine.

Dr. Rafael Gonzalez Alvarez is Chemistry and Biological Analyst by the Autonomous University of Aguascalientes (1999). Dr. Gonzalez studied his Master (2001) and Ph D (2006) in Genetic Engineering and Molecular Biology at the Autonomous University of Nuevo Leon. He has visited the researcher centers at the University of Granada, Spain (1998) and the University of Texas campus Houston (2005). He performed a Post-Doctoral Position (2006-2008) in the Institute of Biomedical Research of the National Autonomous University of Mexico. Dr. Gonzalez was Researcher in the Unit of Medical and Pharmaceutical Biotechnology Center for Research and Assistance in Technology and Design of the State of Jalisco, AC (AC CIATEJ). 2008-2010. Also was Full Professor at the InstitutoTecnologico de EstudiosSuperiores de Monterrey campus Guadalajara. 2010-2014. As a businessman, he founded the technology company 'Biotechnology Kreag SA of C.V. 'RFC BKR090527532'. The company is listed on the National Registry of Scientific and Technological Institutions and Enterprises (RENIECYT), with the number 2010/13124. This registration yielded economic resources of the Fund for Technological Innovation of the Ministry of Economy - CONACYT, with the project 'Production and marketing kit to diagnose PKU' key ECO-2010-C01-000000000144592. With these resources was possible to develop the prototype of the kit. With the prototype a second round of investment was obtained, but now by private investors of Guadalajara. With previous experience, he developed skills such as management, administration, trading and sales; aimed at obtaining public and private resources.

Dr. Shah Giashuddin is working as Chief for Anatomic Pathology Division, New York Presbyterian-Methodist Hospital and Clinical Assistant professor at Weill Medical College of Cornell University. Dr. Giashuddin also worked as Director for The Brooklyn Hospital Center. He is currently involved in joint collaboration with a group of researchers at Virginia Commonwealth University and with NYU School of Medicine. He is primarily involved in routine surgical and cytopathology diagnostic work with a special focus on breast and GYN pathology.

Dr. Pandu Reddy Gangula is working as Associate Professor in Department of Physiology and Chairman for Oral Biology and Research at Meharry Medical College. Dr. Gangula worked as Assistant Professor in Department of Internal Medicine, University of Texas Medical Branch. He has also worked as Research Associate in Department of Clinical Pharmacology at Vanderbilt University. He is also serving as course-coordinator and instructor for Physiology II for graduate students. He has been involved in diabetic and cardiovascular-related research for the past 20 years. As a biomedical research scientist, he has been funded with NIH-RO1’s (NICHD), R21 (NIDDK) and RO3 (NIA) both as a Principal Investigator as well as Co-Investigator. For the past several years, he has been providing research training/teaching/mentoring to post-doctoral fellows, research technicians, junior faculty, clinical residents, medical and dental students. He is actively involved in writing and submitting research proposals, secured NIH funding to conduct research, publishing research findings in peer-reviewed journals, actively involved in reviewing various grant proposals and making funding decisions.

Dr. Abdul Rahman Asif is Professor of molecular medicine and director research at the Institute of Clinical Chemistry, University Medical Center Gottingen (UMG). Beside this, he is responsible for diagnostic units at the UMG-laboratories. Dr. Asif has extensive experience in the field of clinical proteomics, in particular differential proteomics, target elucidation and characterization of PTM. His research group is collaborating with several national and international partners in wide range of clinical research topics. His teaching activities encompass a range of molecular medicine topics and investigative diagnostics. He has authored and co-authored more than 70 peer-reviewed articles on clinical proteomics and molecular medicine.His research interests include ChIP-o-proteomics, Diagnostics, prognostics and therapy monitoring marker for cardiovascular diseases, Identifying novel molecular targets of drugs, Protein - protein and protein - drug interactions, Immuno-proteomics for identification of new diagnostic and vaccine targets.

Prof. Yoshitaka Fukuzawa is currently working as a professor and chairman at Aichi Medical University and Hospital, Aichi Medical Preemptive and Integrative Medicine Center (AMPIMEC) in the division of Gastroenterology and Liver. He was awarded as Best Doctors in Japan (2018-2019), JACA 2019 Achievement Award (Japan Society of Aging Control Medicine), JSHPM 2019 Achievement Award (Japanese Society for Health Promotion Medicine), WFCMS 2019 Achievement Award (World Federation of Chinese Medicine Societies). Dr. Yoshitaka Fukuzawa's research interest includes Ezetimibe for the treatment of non-alcoholic fatty liver disease, Impact of partially hydrolyzed guar gum (PHGG) on constipation prevention, Gastroenterology and Liver, etc.

Dr. Cesare Formisano is an Associate Professor of General Surgery in the Department of Clinical Medicine and Surgery at University of the Studies of Napoli Federico II, Italy. He is a member of numerous national and international scientific surgical societies. Dr. Cesare Formisano has published many works on BioEnterics Intragastric Balloon, Laparotomic vs. Laparoscopic Lap-band and its intermediate complications, Gastric precancerous conditions, etc. Prof. Formisano Cesare’s research interests include Surgical Pathophysiology, Digestive Tract Surgery, Oncological Surgery, Experimental Surgery, Senology, Bariatric Surgery, Endocrine Surgery, Emergency Surgery.

Dr. Bo Jin graduated with a medical degree in 1985 and a PhD in 2005 in China. Additionally, Dr. Jin has completed fellowships at National Institutes of Health, USA and Toyama Medical and Pharmaceutical University, Japan. He currently holds a professorship and his research interests lie with immunology and liver fibrosis. His interests in liver fibrosis research focuses on the use of intrahepatic administration of collagenase for reversal of liver fibrosis and this work was one of the earliest that established proof-of-principle of these potential therapeutic agents. His immunological interest lies with double-stranded RNA induced immune response and its potential application in anti-virus and/or anti-cancer immunotherapy. Professor Jin’s work has received international recognition and he is an awardee of the Fellow’s Award for Research Excellence of the National Institutes of Health, USA in 2004.

Dr. Wensheng Pan is working as Professor and Chief Physician in Gastroenterology Department, Zhejiang University. Dr. Pan received Ph.D. in Pathology from Tokyo Medical University. His Specific Specialty is on The early diagnosis and treatment of the digestive tract as early cancer and found that morphological changes in the characteristics of early gastric cancer with lymph node metastasis. His research experience is mainly involved with- The mechanism of CapG together with Ca2+ involving in the formation of lamellipodia and invadopodia during gastric cancer cell migration- the national natural science foundation of china; The role of Akt2 in the tumorigenesis and metastasis of colorectal cancer stem cells-The Natural Science Foundation of Zhejiang Province.

Dr. Toru Ishikawa is working as General Manager in the Department of Gastroenterology, Saiseikai Niigata Daini Hospital. Dr. Ishikawa was worked as Head Doctor of Gastroenterology, Saiseikai Niigata Daini Hospital (2002-2007). Dr. Ishikawa was a Resident in the Third Department of Internal Medicine in the Niigata University Hospital, Niigata, Japan. His research interest includes-Hepatocellular carcinoma, Portal hypertension, Hepatitis.

Dr. Chaohui Yu is Chief Physician of Gastroenterology in Zhejiang University. Dr. Yu completed one Natural Science Foundation of China (NSFC), two Zhejiang science and technology development plans. Now he is having two Natural Science Foundation of China (NSFC). Participating one key research project supported by National Natural Science Foundation. He received provincial science and technology awards five times with main participants. His research interests include Nonalcoholic Fatty Liver Disease; Liver Diseases; Inflammatory bowel diseases; Pancreatic Disorders; Disorders of the Colon and Rectum; Crohn's Disease.

Dr. Hongzheng Ren is working as Associate Professor for Pathology Department at Henan University. Dr. Ren is Director of Pathology Department in the People's Hospital. Dr. Ren holds a Ph.D. from Xiangya Medical College Central South University. He holds Master Degree in Pathology Department from Zhengzhou University. He worked as Physician in The Shanghai Cancer Hospital, Fudan University. His research mainly concentrate in the field of esophageal carcinoma, lung cancer and breast cancer's molecular biology, immunotherapeutic approach and genetic analysis of candidate genes.

Dr. Junjun Wang is working as Professor in China Agriculture University and Assistant Director at Ministry of Agriculture Feed Industry Centre, China. Dr. Wang worked as an Associate professor in same university (2007-2013). He was a Visiting Scholar at Texas A&M University (2005-2006). He completed his B.S, M.S from University of Agriculture and Animal Science, Ph.D from Beijing Institute of Biotechnology, China. His research interest include Physiological defects of low birth weight pig and its nutritional regulation; Nutrition and Animal Reproduction; Metabolomics and personalized nutrition.

Dr. Yang received his B.S. from the School of Gannan Medical College in Jiangxi in 2003. He received his M.S. in 2006 and his Ph.D. in 2010 from Guangzhou Medical University in Guangzhou, China. In 2007, he joined Yu-Jui Yvonne Wan's lab in University of Kansas Medical Center to study molecular biology of the liver cancer. After two years, he worked as postdoctoral fellow in Wan’s lab. In 2010, Dr. Yang was recruited by the Department of Gastroenterology of the Second Affiliated Hospital in Guangzhou Medical University. His studies focus on the molecular mechanisms of HDACi antitumor effects and the pathophysiology of the liver with specific interests in understanding the mechanism underlying the development of metabolic syndromes, fatty liver, fibrosis, cirrhosis, and liver cancer. The goal is to identify potential therapeutic targets in the prevention and treatment of liver disease.

Dr. Gary Heng-Liang Lin is currently working for Fu Jen Catholic University Hospital as a Director of Department of Fund Management, Deputy Director of Center for Innovation and General Secretary of Cell Therapy Group. Dr. Lin has academic experiences at Institute of Biotechnology and Pharmaceutical Research, National Health Research Institute (NHRI) and been focusing on occlusive/ hemorrhage strokes, Idiopathic thrombocytopenic purpura, diabetic nephropathy, myocarditis and polycystic kidney disease-related aneurysm. Dr. Gary Heng-Liang Lin received his Ph.D in 2001 from National Yang-Ming University, Taiwan. Dr. Gary research interests includes Drug and Med-tech repurposing, Clinical trial design, Translational research, Chemotherapy/ radiation related neuropathic pain (ICD G62.0/ G62.9/ D49.9) Malignant fatigue (thrombocytopenia/ purpura) (ICD R53.0), Mechanism of botanical-derived medicines, Specialty pharmaceutical formulation, Lyophilized technologies for PRP, antibody, stem cells derived factors.

Dr. Diana Anca is working as Director of NORA(Non-Operating Room Anesthesiology), and Assistant Professor of Clinical Anesthesiology Department. Dr. Diana Anca research interests include Anesthesia in the remote locations, Electrophysiology, Interventional Radiology and Gastroenterology Suites, etc.